CDH11 and cancer: Then, we assessed the suitability of CDH11 as a potential therapeutic target for SACC and observed its robust expression in SACC, specifically in hybrid EMT cells and cancer‐associated fibroblasts (CAFs) (Figure S4C–E, Supporting Information).